{"id":"W3042832159","doi":"10.1016/j.drup.2020.100719","title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","year":2020,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lopinavir; Hydroxychloroquine; Favipiravir; Ritonavir; Azithromycin; Clinical trial; Chloroquine; Pharmacology; Intensive care medicine; Virology; Immunology; Disease; Antibiotics; Coronavirus disease 2019 (COVID-19); Malaria; Virus; Internal medicine; Viral load; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583313,0.0008702277,0.00188088,0.002000822,0.000235953,0.001396386,0.0009101007,0.001276728,0.0123264],"category_scores_gemma":[0.002020383,0.0003057643,0.00140837,0.001708715,0.0004034287,0.00106249,0.0006953441,0.002239272,0.002742023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009635602,"about_ca_system_score_gemma":0.00235858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001732428,"about_ca_topic_score_gemma":0.005626347,"domain_scores_codex":[0.9996879,0.00007257619,0.00005474656,0.00004003641,0.0001009883,0.00004384815],"domain_scores_gemma":[0.9990741,0.0004463631,0.0001822941,0.00002033683,0.0002175479,0.00005922807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003975626,0.0001143522,0.0001642854,0.02578168,0.0002614485,0.0001201805,0.00003669655,0.0002627916,0.001551374,0.002226647,0.04487243,0.9242105],"study_design_scores_gemma":[0.0004774956,0.0005811134,0.00106335,0.01554953,0.001127071,0.0005056564,0.00005621797,0.0001624896,0.0006438953,0.001140739,0.9786654,0.0000270167],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003289312,0.9948217,0.0001940296,0.0008042588,0.0003258424,0.00004583908,0.0002224247,0.00002744992,0.00322946],"genre_scores_gemma":[0.001992213,0.9946229,0.0005252087,0.001232471,0.000170322,0.00003727933,0.0002607899,0.000005051038,0.001153835],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0123264,"threshold_uncertainty_score":0.04123586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.12587865412803,"score_gpt":0.4819622007752686,"score_spread":0.3560835466472386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}